When stress no longer automatically translates to thoughts of drinking, one of the most common relapse triggers loses its power
Another randomized-placebo controlled study failed to find improvements in any glycemia control marker in therapy-nave DM patients undergoing a 28-day therapy with eight daily capsules of either MO (4 g/d) or placebo [22].A non-significant reduction of 34% of initial values was found in HbA1c as compared to baseline in both treatment arms, which reflected that self-monitoring plasma glucose provides feedback that improves glycemic control through lifestyle changes
The company also said it explicitly discloses that compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality, ensuring transparency in its messaging
The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest
Filed Under: Metabolic disease/endicrinology
Patient education : Comprehensive training on injection technique, recognition of hypoglycaemia (when used with other glucose-lowering medications), and sick day rules
